fbpx
Medical Innovation Exchange

Biogen takes nuclear option, terminating Karyopharm ALS pact after getting a look at phase 1 data

https://www.fiercebiotech.com/biotech/biogen-takes-nuclear-option-terminating-karyopharm-als-pact-after-getting-look-phase-1-data

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.